Platelet Glycoprotein IIb/IIIa Inhibitors Reduce Mortality in Diabetic Patients With Non–ST-Segment Elevation Acute Coronary Syndromes

ACC Current Journal Review
doi 10.1016/s1062-1458(02)00618-9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Cost-Effectiveness of Platelet Glycoprotein IIb/IIIa Inhibition With Eptifibatide in Patients With Non-St-Elevation Acute Coronary Syndromes

Circulation
Cardiovascular MedicinePhysiologyCardiology
2000English

Current Role of Platelet Glycoprotein IIb/IIIa Inhibitors in Acute Coronary Syndromes

JAMA - Journal of the American Medical Association
Medicine
2000English

Acute Coronary Syndromes Without ST Segment Elevation

BMJ
2007English

Clopidogrel to Treat Patients With Non–ST-Segment Elevation Acute Coronary Syndromes After Hospital Discharge

Archives of Internal Medicine
2006English

Routine Upstream Initiation vs Deferred Selective Use of Glycoprotein IIb/IIIa Inhibitors in Acute Coronary Syndromes

JAMA - Journal of the American Medical Association
Medicine
2007English

Clinical Significance of Thrombocytopenia During a Non ST-Elevation Acute Coronary Syndrome : The Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial Experience

Circulation
Cardiovascular MedicinePhysiologyCardiology
1999English

Glycoprotein IIb/IIIa Induced Coronary Thrombolysis

Heart
2002English

Deaths Associated With Platelet Glycoprotein IIb/IIIa Inhibitor Treatment

Heart
2003English

Platelet Inhibition With an Antibody to Glycoprotein IIb/IIIa

Circulation
Cardiovascular MedicinePhysiologyCardiology
1989English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy